Maganin bushewar ido na farko tare da fasahar nanomicellar

A KYAUTA Kyauta 4 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Sun Pharma Canada Inc. a yau ta sanar da ƙaddamar da CEQUA, sabon magani ga mutanen Kanada masu fama da bushewar ido. CEQUA (cyclosporine ophthalmic bayani 0.09% w / v), mai hanawa na calcineurin immunomodulator, shine farkon busasshen maganin ido da ake samu a Kanada wanda aka isar da shi tare da fasahar nanomicellar (NCELL), wanda ke haɓaka haɓakar bioavailability da kwanciyar hankali na physicochemical na cyclosporine don haɓaka shigar da nama na ido. .    

"Muna farin cikin gabatar da CEQUA a matsayin sabon zaɓin magani ga 'yan Kanada fiye da miliyan shida da ke fama da bushewar cututtukan ido1," in ji Abhay Gandhi, Shugaba na Arewacin Amirka, Sun Pharma. "Wannan ƙaddamar da wani muhimmin ci gaba ne ga Sun Pharma yayin da muke fadada fayil ɗin mu na ido zuwa Kanada kuma yana nuna ƙaddamar da mu don samar da sabbin magunguna don tallafawa zaɓin mara lafiya da likita."

Baya ga yawaitar da ta yi a baya a tsakanin mutanen kasar Kanada, wani rahoto na baya-bayan nan daga Cibiyar Bincike da Ilimi ta Ido (CORE) ya nuna cewa yawan busasshen cututtukan ido yana karuwa saboda karuwar sanya abin rufe fuska, wanda zai iya haifar da bushewar tabo a kan. fuskar ido.2

"Muna farin cikin ganin sabon samfurin da ake samu yanzu ga yawancin mutanen Kanada da ke fama da keratoconjunctivitis sicca ko busassun cututtukan ido," in ji W. Bruce Jackson, MD, tsohon Farfesa da Shugaba, Sashen Ophthalmology, Jami'ar McGill da Jami'ar Ottawa. "CEQUA, tare da fasahar nanomicellar sa da kuma ƙara ƙarfin cyclosporine, na iya zama muhimmin ƙari ga zaɓuɓɓukan jiyya kamar yadda ƙwararrun kula da ido ke ƙoƙarin samun ƙarin jiyya na musamman."

 

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...